via University of Oxford
Scientists have developed a world-first diagnostic test, powered by artificial intelligence, that can identify known respiratory viruses within five minutes from just one nasal or throat swab.
The new diagnostic test could replace current methods that are limited to testing for only one infection, such as a lateral flow test for COVID-19, or otherwise are either lab-based and time-consuming or fast and less accurate.
The new virus detection and identification methodology is described in a paper published in ACS Nano, authored by DPhil student Nicolas Shiaelis and Professor Achillefs Kapanidis from the Department of Physics, and Dr Nicole Robb from the University of Warwick who is a Visiting Lecturer at Oxford’s Department of Physics.
The paper demonstrates how machine learning can significantly improve the efficiency, accuracy and time taken to not only identify different types of viruses, but also differentiate between strains.
Nicolas Shiaelis and Dr Robb collaborated with the John Radcliffe Hospital to validate the new method. The ground-breaking testing technology combines molecular labelling, computer vision and machine learning to create a universal diagnostic imaging platform that looks directly at a patient sample and can identify which pathogen is present in a matter of seconds – much like facial recognition software, but for germs.
Preliminary research demonstrated that the test could identify the COVID-19 virus in patient samples and further work determined that the test could be used to diagnose multiple respiratory infections, within five minutes and with over 97% accuracy.
Dr Robb and Nicolas Shiaelis founded Pictura Bio, a University of Oxford spinout, that now licences the technology. They are now looking for further investment to accelerate development and get it to the front line of healthcare.
‘Our aim at Pictura Bio is to turn the method into a diagnostic test by creating a dedicated imager and single-use cartridge for use in point-of-care testing, with limited input from the user. We are also expanding the number of viruses that the models are trained on and will eventually start looking at other pathogens, such as bacteria and fungi, in respiratory samples, blood and urine.’
Nicolas Shiaelis
Dr Robb said: ‘Cases of respiratory infections this winter have hit record-breaking highs, increasing the number of people seeking medical help. This combined with the COVID-19 backlog, staff shortages, tighter budgets and an ageing population puts the NHS and its workforce under immense and unsustainable pressure.
‘Our simplified method of diagnostic testing is quicker and more cost-effective, accurate and future proof than any other tests currently available. If we want to detect a new virus, all we need to do is retrain the software to recognise it, rather than develop a whole new test. Our findings demonstrate the potential for this method to revolutionise viral diagnostics and our ability to control the spread of respiratory illnesses.’
Original Article: Oxford scientists develop test that can identify respiratory viruses within five minutes
More from: University of Oxford | University of Warwick
The Latest Updates from Bing News
Go deeper with Bing News on:
Respiratory virus test
- US respiratory virus levels continue to decline as officials track shift in SARS-CoV-2 proportions
Amid further declines in COVID activity, the CDC reported a steady rise in JN.1 spinoffs that have 2 added spike mutations, part of a group nicknamed FLiRT.
- Common antibiotic Neosporin may shield against viral respiratory infections
A study conducted first in mice and then in human volunteers suggests that a common antibiotic, neomycin, which is the main active ingredient in Neosporin, may help protect against viral respiratory ...
- Respiratory syncytial virus seasonality, transmission zones, and implications for seasonal prevention strategy in China: a systematic analysis
Although substantial variations in RSV seasonality were observed across provinces of China, our study identified distinct transmission zones with shared RSV circulating patterns. These findings could ...
- New test to identify respiratory viruses in 24 hours
New pathology tests will soon let Australians know which virus they have within 24 hours ... or one of 14 different respiratory viruses. It will be available at GPs and will have a similar ...
- New Australian-made test checks for 14 respiratory viruses, including COVID-19, RSV and influenza
Aussie scientists have developed a test that can identify 14 different ... deadly infection – an enterovirus or respiratory syncytial virus (RSV) could land them in hospital.
Go deeper with Bing News on:
Viral diagnostics
- Calls for Hong Kong to offer hepatitis B screening to specific age groups in bid to eliminate viral infection
The World Health Organization has set a global goal of achieving a 90 per cent diagnostic rate by 2030 to eliminate the ... The department said the steering committee on prevention and control of ...
- Mom shares viral TikTok about sending kids to school in stained, clean clothes
Marla Branyan said she wants her kids to feel free to play and get messy, and that parents shouldn't feel shame around dressing their kids in stained clothes.
- Owlstone secures $6.5M for breath-based diagnostics for infectious disease
Owlstone Medical has secured a $5 million equity investment and initial $1.5 million grant funding, committed by the Bill and Melinda Gates Foundation, for development of breath-based diagnostic ...
- Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease
Early diagnosis is a critical determinant of health outcomes ... will work to identify a panel of on-breath candidate VOC biomarkers that correlate with HIV viral load. The data collected will also be ...
- Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced today ...